A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
Schwartzberg LS, Yee LK, Senecal FM, et al.
Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma.
Taniguchi Y, Okura M
Head Neck 2003;25(11):931-936.
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.
Hedenus M, Adriansson M, Miguel JS, et al.
Br J Haematol 2003;122(3):394-403.
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
Cazzola M, Beguin Y, Kloczko J, Spicka I, Coiffier B
Br J Haematol 2003;122(3):386-393.
Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy.
This is a well done study of anemic cancer patients on cisplatin chemotherapy that documents nicely that the best predictor of an ultimate good response... Read More
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy.
Vansteenkiste J, Pirker R, Massuti B, et al.
J Natl Cancer Inst 2002;94(16):1211-1220.
Review by Ford PA
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Sajdak S, Moszynski R, Opala T
Eur J Gynaecol Oncol 2002;23(4):325-326.
Place of normovolemic hemodilution in oncologic cervicofacial and ENT surgery. [Article in French]
Boussofara M, Damak R, Bracco D, Ravussin P
Ann Fr Anesth Reanim 2002;21(4):271-275.
Review by Van der Linden P